Specialized Pro-resolving Mediators (SPMs) in Real World Clinical Practice presented by Jennifer Stagg, ND
Jennifer Stagg, ND, is a healthcare practitioner in Connecticut who actively uses nutritional solutions to help her patients achieve better health. She frequently sees patients who are experiencing chronic inflammation. In this webinar, she describes her experience seeing patients who have conditions that involve chronic inflammation and the solutions she uses to manage the underlying inflammation and the condition itself.
We know that chronic inflammation is caused by obesity, poor lifestyle, and aging and is associated with a variety of conditions that lead to arthritis, cancer, atherosclerosis, neurological diseases, and insulin resistance and type 2 diabetes.
The first step in the process to see if SPMs are an appropriate therapy for a particular patient is assessment. Providers can measure clinically relevant biomarkers of inflammation like hsCRP, TNF-alpha, Ferritin, ESR, and Fibrinogen. Patients might also measure their quality of life by taking a brief pain inventory, such as the American Chronic Pain Association Quality of Life Scale.
